Berberine treatment suppressed the mRNA expression of extracellular matrix–degrading proteinases MMP2 and urokinase-plasminogen activator (u-PA), which are closely associated with the invasive and metastatic potential of lung cancer cells [93,120]. This evidence concerns the gene MMP2 and lung cancer.